BusinessSun Pharma Board to Approve ₹15,000 Crore NCD Issue on October 12
Sun Pharmaceutical Industries will hold a board meeting on October 12, 2026, to approve the issuance of non-convertible debentures worth up to ₹15,000 crore. The funds raised will be used to finance a bridge loan for acquiring Organon & Co.
Mint Markets·


